ebm.bmj12d
Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India
Background Health technology assessment (HTA) is a valuable tool for informing the efficient allocation of resources in ...
ebm.bmj7d
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation
New government legislation is necessary to ensure full transparency of industry payments in the UK’s healthcare. A first step ...
ebm.bmj4d
Opportunities, challenges and risks of using artificial intelligence for evidence synthesis
Artificial intelligence (AI) is developing rapidly. In particular, in the area of machine learning (ML), significant progress ...
ebm.bmj9d
Cholesterol paradox: a correlate does not a surrogate make
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj5d
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
Correspondence to Dr Preeti Malik, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; pmalik.ma{at}gmail.com Objective To evaluate association between biomarkers and outcomes in ...
ebm.bmj10d
Modest cancer prevention benefit with long-term multivitamin supplementation: Physicians’ Health Study II results warrant cautious interpretation
Department of Nutrition Sciences, University of Alabama, Birmingham, Alabama, USA Correspondence to Wendy Demark-Wahnefried Department of Nutrition Sciences, University of Alabama, 1675 University ...
ebm.bmj9d
Emollients and smoking: a fire hazard that could be prevented to reduce future deaths
Correspondence to Dr Maja Karolina Bilip, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK; maja.bilip{at}doctors.net.uk Emollients are readily available in prescription and ...
ebm.bmj9d
Paracetamol as first line for treatment of knee and hip osteoarthritis
Correspondence to Dr Igho J Onakpoya, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK; igho.onakpoya{at}phc.ox.ac.uk Although several clinical guidelines ...
ebm.bmj11d
Inclusion and exclusion criteria and the problem of describing homogeneity of study populations in clinical trials
Correspondence to Dr Franz Porzsolt, Health Care Research at the Dept General and Visceral Surgery, University Hospital Ulm, Ulm 89071, Germany; f.porzsolt{at}gmx.de The description of results in ...